Key result
Aggressive pericardiocentesis and intravenous linezolid successfully treated purulent pericarditis caused by community-acquired MRSA in an 18-year-old male, with no residual effusion at 3 months.
Why the study?
Pericarditis due to MRSA is rarely reported in the literature without risk factors such as immunosuppression, thoracic surgery, chest trauma, or pre-existing pericardial diseases.
Case Report (n=1)
Highlights the importance of aggressive pericardiocentesis and appropriate antibiotic therapy in rare cases of CA-MRSA purulent pericarditis.
May guide therapy in rare CA-MRSA pericarditis; leaves open optimal regimen and generalizability.
INTRODUCTION: (CA-MRSA) in the last few decades. Pericarditis due to MRSA is rarely reported in the literature without risk factors like immunosuppression, thoracic surgery, chest trauma or pre-existing pericardial diseases. CASE REPORT: We describe an 18-year-old male who presented with 5 days history of fever, chest pain and shortness of breath. Echocardiogram and thorax CT showed significant pericardial effusion. The patient underwent pericardiocentesis, MRSA was isolated from blood and pericardial fluid. The patient improved with intravenous antibiotics (linezolid). Follow-up echocardiography at 3 months was unremarkable, without any residual fluid or features of constrictive pericarditis. DISCUSSION: In the absence of known risk factors, MRSA is an extremely rare cause of pericarditis in modern antibiotics era. The possibility of MRSA pericarditis should be sought in every case of pericarditis to achieve prompt diagnosis and treatment. CONCLUSIONS: Our case highlights the role of aggressive pericardiocentesis and appropriate antibiotic therapy in purulent pericarditis.
No takes yet. Share an insight, caveat, or question.
Meena et al. (2020) conducted a case report in Purulent pericarditis due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) (n=1). Pericardiocentesis and intravenous linezolid was evaluated on Clinical improvement and resolution of pericardial effusion. Aggressive pericardiocentesis and intravenous linezolid successfully treated purulent pericarditis caused by community-acquired MRSA in an 18-year-old male, with no residual effusion at 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: